Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076403457> ?p ?o ?g. }
- W2076403457 endingPage "38501" @default.
- W2076403457 startingPage "38486" @default.
- W2076403457 abstract "Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease caused by insufficient expression of frataxin (FXN), a mitochondrial iron-binding protein required for Fe-S cluster assembly. The development of treatments to increase FXN levels in FRDA requires elucidation of the steps involved in the biogenesis of functional FXN. The FXN mRNA is translated to a precursor polypeptide that is transported to the mitochondrial matrix and processed to at least two forms, FXN42–210 and FXN81–210. Previous reports suggested that FXN42–210 is a transient processing intermediate, whereas FXN81–210 represents the mature protein. However, we find that both FXN42–210 and FXN81–210 are present in control cell lines and tissues at steady-state, and that FXN42–210 is consistently more depleted than FXN81–210 in samples from FRDA patients. Moreover, FXN42–210 and FXN81–210 have strikingly different biochemical properties. A shorter N terminus correlates with monomeric configuration, labile iron binding, and dynamic contacts with components of the Fe-S cluster biosynthetic machinery, i.e. the sulfur donor complex NFS1·ISD11 and the scaffold ISCU. Conversely, a longer N terminus correlates with the ability to oligomerize, store iron, and form stable contacts with NFS1·ISD11 and ISCU. Monomeric FXN81–210 donates Fe2+ for Fe-S cluster assembly on ISCU, whereas oligomeric FXN42–210 donates either Fe2+ or Fe3+. These functionally distinct FXN isoforms seem capable to ensure incremental rates of Fe-S cluster synthesis from different mitochondrial iron pools. We suggest that the levels of both isoforms are relevant to FRDA pathophysiology and that the FXN81–210/FXN42–210 molar ratio should provide a useful parameter to optimize FXN augmentation and replacement therapies. Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease caused by insufficient expression of frataxin (FXN), a mitochondrial iron-binding protein required for Fe-S cluster assembly. The development of treatments to increase FXN levels in FRDA requires elucidation of the steps involved in the biogenesis of functional FXN. The FXN mRNA is translated to a precursor polypeptide that is transported to the mitochondrial matrix and processed to at least two forms, FXN42–210 and FXN81–210. Previous reports suggested that FXN42–210 is a transient processing intermediate, whereas FXN81–210 represents the mature protein. However, we find that both FXN42–210 and FXN81–210 are present in control cell lines and tissues at steady-state, and that FXN42–210 is consistently more depleted than FXN81–210 in samples from FRDA patients. Moreover, FXN42–210 and FXN81–210 have strikingly different biochemical properties. A shorter N terminus correlates with monomeric configuration, labile iron binding, and dynamic contacts with components of the Fe-S cluster biosynthetic machinery, i.e. the sulfur donor complex NFS1·ISD11 and the scaffold ISCU. Conversely, a longer N terminus correlates with the ability to oligomerize, store iron, and form stable contacts with NFS1·ISD11 and ISCU. Monomeric FXN81–210 donates Fe2+ for Fe-S cluster assembly on ISCU, whereas oligomeric FXN42–210 donates either Fe2+ or Fe3+. These functionally distinct FXN isoforms seem capable to ensure incremental rates of Fe-S cluster synthesis from different mitochondrial iron pools. We suggest that the levels of both isoforms are relevant to FRDA pathophysiology and that the FXN81–210/FXN42–210 molar ratio should provide a useful parameter to optimize FXN augmentation and replacement therapies. Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly.Journal of Biological ChemistryVol. 286Issue 10PreviewVOLUME 285 (2010) PAGES 38486–38501 Full-Text PDF Open Access" @default.
- W2076403457 created "2016-06-24" @default.
- W2076403457 creator A5016287902 @default.
- W2076403457 creator A5024827774 @default.
- W2076403457 creator A5027907673 @default.
- W2076403457 creator A5053223762 @default.
- W2076403457 creator A5057461093 @default.
- W2076403457 creator A5065330135 @default.
- W2076403457 date "2010-12-01" @default.
- W2076403457 modified "2023-09-29" @default.
- W2076403457 title "Normal and Friedreich Ataxia Cells Express Different Isoforms of Frataxin with Complementary Roles in Iron-Sulfur Cluster Assembly" @default.
- W2076403457 cites W1966055504 @default.
- W2076403457 cites W1976839484 @default.
- W2076403457 cites W1984104940 @default.
- W2076403457 cites W1986581289 @default.
- W2076403457 cites W1989255793 @default.
- W2076403457 cites W2006178088 @default.
- W2076403457 cites W2009265061 @default.
- W2076403457 cites W2012477909 @default.
- W2076403457 cites W2014389088 @default.
- W2076403457 cites W2022708198 @default.
- W2076403457 cites W2027452510 @default.
- W2076403457 cites W2030356875 @default.
- W2076403457 cites W2031212222 @default.
- W2076403457 cites W2043666185 @default.
- W2076403457 cites W2045213984 @default.
- W2076403457 cites W2058276214 @default.
- W2076403457 cites W2071849674 @default.
- W2076403457 cites W2075154209 @default.
- W2076403457 cites W2075817699 @default.
- W2076403457 cites W2077687448 @default.
- W2076403457 cites W2078448486 @default.
- W2076403457 cites W2080731376 @default.
- W2076403457 cites W2080851578 @default.
- W2076403457 cites W2081936723 @default.
- W2076403457 cites W2091848369 @default.
- W2076403457 cites W2094754882 @default.
- W2076403457 cites W2095184629 @default.
- W2076403457 cites W2096392022 @default.
- W2076403457 cites W2108689460 @default.
- W2076403457 cites W2115953418 @default.
- W2076403457 cites W2119863500 @default.
- W2076403457 cites W2120039680 @default.
- W2076403457 cites W2120481130 @default.
- W2076403457 cites W2121157958 @default.
- W2076403457 cites W2122609691 @default.
- W2076403457 cites W2124756854 @default.
- W2076403457 cites W2125078806 @default.
- W2076403457 cites W2126923900 @default.
- W2076403457 cites W2136321020 @default.
- W2076403457 cites W2137995714 @default.
- W2076403457 cites W2138672060 @default.
- W2076403457 cites W2139217585 @default.
- W2076403457 cites W2139975428 @default.
- W2076403457 cites W2141894532 @default.
- W2076403457 cites W2143361020 @default.
- W2076403457 cites W2144097910 @default.
- W2076403457 cites W2158155007 @default.
- W2076403457 cites W2158892672 @default.
- W2076403457 cites W2168176110 @default.
- W2076403457 cites W2171401176 @default.
- W2076403457 cites W2172149645 @default.
- W2076403457 doi "https://doi.org/10.1074/jbc.m110.145144" @default.
- W2076403457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3048758" @default.
- W2076403457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20889968" @default.
- W2076403457 hasPublicationYear "2010" @default.
- W2076403457 type Work @default.
- W2076403457 sameAs 2076403457 @default.
- W2076403457 citedByCount "71" @default.
- W2076403457 countsByYear W20764034572012 @default.
- W2076403457 countsByYear W20764034572013 @default.
- W2076403457 countsByYear W20764034572014 @default.
- W2076403457 countsByYear W20764034572015 @default.
- W2076403457 countsByYear W20764034572016 @default.
- W2076403457 countsByYear W20764034572017 @default.
- W2076403457 countsByYear W20764034572018 @default.
- W2076403457 countsByYear W20764034572019 @default.
- W2076403457 countsByYear W20764034572020 @default.
- W2076403457 countsByYear W20764034572021 @default.
- W2076403457 countsByYear W20764034572022 @default.
- W2076403457 crossrefType "journal-article" @default.
- W2076403457 hasAuthorship W2076403457A5016287902 @default.
- W2076403457 hasAuthorship W2076403457A5024827774 @default.
- W2076403457 hasAuthorship W2076403457A5027907673 @default.
- W2076403457 hasAuthorship W2076403457A5053223762 @default.
- W2076403457 hasAuthorship W2076403457A5057461093 @default.
- W2076403457 hasAuthorship W2076403457A5065330135 @default.
- W2076403457 hasBestOaLocation W20764034571 @default.
- W2076403457 hasConcept C104317684 @default.
- W2076403457 hasConcept C11701378 @default.
- W2076403457 hasConcept C12554922 @default.
- W2076403457 hasConcept C131934819 @default.
- W2076403457 hasConcept C169760540 @default.
- W2076403457 hasConcept C181199279 @default.
- W2076403457 hasConcept C185592680 @default.
- W2076403457 hasConcept C2777852564 @default.
- W2076403457 hasConcept C2779314966 @default.
- W2076403457 hasConcept C2779369046 @default.